Evidence map›Paper›PMID 38095659›Full record

ReviewDer Nervenarzt2024

[Dementia with Lewy bodies: old and new knowledge-Part 2: treatment].

Richard Dodel, Daniela Berg, Thomas Duning, Elke Kalbe, Philipp T Meyer, Alfredo Ramirez, Alexander Storch, Dag Aarsland, Frank Jessen

Abstract readEnglish AbstractReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Der Nervenarzt, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Behavioral disorders in dementia with Lewy bodies: old and new knowledge.Journal of neural transmission (Vienna, Austria : 1996) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Richard DodelLehrstuhl für Geriatrie, Universität Duisburg-Essen, Virchowstraße 171, 45147, Essen, Deutschland. richard.dodel@uk-essen.de.
Daniela BergNeurologische Klinik, Universität Kiel, Kiel, Deutschland.
Thomas DuningNeurologische Klinik, Universität Münster, Münster, Deutschland.
Elke KalbeMedizinische Psychologie, Neuropsychologie und Gender Studies & Centrum für Neuropsychologische Diagnostik und Intervention (CeNDI), Universität Köln, Köln, Deutschland.
Philipp T MeyerKlinik für Nuklearmedizin, Universitätsklinikum Freiburg, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, Freiburg, Deutschland.
Alfredo RamirezKlinik und Poliklinik für Psychiatrie und Psychotherapie, Universität Köln, Köln, Deutschland.
Alexander StorchKlinik für Neurologie, Universität Rostock, Rostock, Deutschland.
Dag AarslandCentre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway; Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, Großbritannien.
Frank JessenKlinik und Poliklinik für Psychiatrie und Psychotherapie, Universität Köln, Köln, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe treatment of patients with dementia with Lewy bodies (DLB) is multifaceted, as motor symptoms, cognitive symptoms, behavioral and psychological symptoms can occur in different constellations. In addition, the use of certain medications is limited (e.g., neuroleptics).

objectiveTo summarize the main recent findings on the treatment of DLB.

resultsTo date, there is no approved therapeutic option for the treatment of patients with DLB in Germany; moreover, the evidence base for pharmacological and non-pharmacological treatment is sparse. The currently consented treatment options are based on the treatment of motor symptoms in the same way as the treatment of Parkinson's disease and for behavioral symptoms based on the treatment for Alzheimer's disease. DISCUSSION: The treatment of DLB with its various symptoms is difficult and often can only be adequately achieved for the patient in close cooperation with a specialist.

Indexed as

Alzheimer DiseaseLewy Body DiseaseParkinson DiseaseGermanyHumansBehavioral and psychological symptomsCholinesterase inhibitorsDementiaParkinson’s disease with dementiaTreatment

Identifiers

PMID38095659
PMCPMC11014874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.